| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.18▲ | 1.18▲ | 1.18▲ | 1.22▼ | 1.16▲ |
| MA10 | 1.19▼ | 1.19▼ | 1.20▼ | 1.18▲ | 1.11▲ |
| MA20 | 1.22▼ | 1.23▼ | 1.24▼ | 1.14▲ | 1.17▲ |
| MA50 | 1.28▼ | 1.24▼ | 1.18▲ | 1.11▲ | 2.11▼ |
| MA100 | 1.20▼ | 1.16▲ | 1.15▲ | 1.18▲ | 5.42▼ |
| MA200 | 1.15▲ | 1.15▲ | 1.12▲ | 1.37▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.007▼ | -0.012▼ | 0.006▲ | N/A |
| RSI | 38.794▼ | 39.635▼ | 43.511▼ | 52.572▲ | 39.368▼ |
| STOCH | 43.056 | 26.111 | 19.048▼ | 55.879 | 59.976 |
| WILL %R | -60.000 | -71.429 | -75.000▼ | -57.357 | -53.908 |
| CCI | -35.000 | -53.057 | -56.494 | 19.307 | 103.406▲ |
|
Wednesday, August 07, 2019 06:10 PM
Clearside Biomedical Inc. (NASDAQ:CLSD) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Jenny Kobin – Investor Relations George Lasezkay – Chief Executive ...
|
|
Wednesday, August 07, 2019 01:39 PM
Clearside Biomedical (NASDAQ:CLSD): Q2 GAAP EPS of -$0.15 beats by $0.25. Revenue of $0.05M beats by $0.04M. Cash and equivalents of $26.2M.
|
|
Wednesday, August 07, 2019 01:05 PM
ALPHARETTA, Ga., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/08/19 | 1.20 | 1.22 | 1.155 | 1.18 | 350,300 |
| 15/08/19 | 1.22 | 1.22 | 1.15 | 1.16 | 240,000 |
| 14/08/19 | 1.27 | 1.27 | 1.20 | 1.20 | 241,100 |
| 13/08/19 | 1.33 | 1.33 | 1.26 | 1.28 | 275,296 |
| 12/08/19 | 1.33 | 1.35 | 1.26 | 1.30 | 765,200 |
| 09/08/19 | 1.33 | 1.44 | 1.223 | 1.32 | 1,317,800 |
| 08/08/19 | 1.07 | 1.30 | 1.06 | 1.285 | 1,831,087 |
| 07/08/19 | 0.9925 | 1.00 | 0.9867 | 0.9948 | 181,298 |
| 06/08/19 | 1.025 | 1.025 | 0.9985 | 1.005 | 343,306 |
| 05/08/19 | 1.07 | 1.08 | 1.03 | 1.06 | 203,300 |
|
|
||||
|
|
||||
|
|